Neilson D, Kavanagh J P, Rao P N
Department of Urology, Manchester University Hospitals, Withington, UK.
Cytokine. 1996 Dec;8(12):938-43. doi: 10.1006/cyto.1996.0126.
The interrelationship between cytokines and their natural antagonists in patients with systemic sepsis are incompletely understood. We have followed the changes in serum levels of TNF-alpha and the two soluble receptors (TNF-sr) in a clinical model of post-operative sepsis. Serial blood samples were taken in patients undergoing percutaneous nephrolithotomy (PCNL) starting pre-operatively and continuing for 24 h thereafter. The levels of TNF-alpha and TNF-sr were raised in patients who became clinically septic and correlated well with the severity of sepsis (using the APACHE III score). In septic patients there was no difference in the pattern of changes in the two types of receptor (TNF-sr55 and TNF-sr75). However, in non-septic patients TNF-sr75 was higher in those with endotoxaemia than those without. This difference was not observed with TNF-sr55 which suggests a different mechanism of release or degree of sensitivity for the two soluble receptors. Regardless of severity of illness, the levels of all three molecules (TNF-alpha and the two receptors) appeared to start rising at about the same time point. The peak TNF-alpha level was reached earlier (2-4 h) than that of the two TNF-sr (4-8 h). The relative rise in TNF-alpha was greater than that of the soluble receptors and this difference was even more marked in those with more severe sepsis. The relationship between peak TNF-alpha and peak TNF-sr was non-linear and the concentration of each TNF-sr appeared to plateau at the higher levels of TNF-alpha. This suggests the exhaustion of a limited pool or saturation of the rate of release. Taken together, these results suggest sepsis develops because of delayed and insufficient secretion of TNF-sr compared with TNF-alpha.
全身性脓毒症患者体内细胞因子与其天然拮抗剂之间的相互关系尚未完全明确。我们在术后脓毒症的临床模型中追踪了肿瘤坏死因子-α(TNF-α)及两种可溶性受体(TNF-sr)的血清水平变化。对接受经皮肾镜取石术(PCNL)的患者,从术前开始连续采集血样,并在术后持续24小时。临床发生脓毒症的患者体内TNF-α和TNF-sr水平升高,且与脓毒症严重程度(采用急性生理与慢性健康状况评分系统III [APACHE III]评分)密切相关。在脓毒症患者中,两种类型的受体(TNF-sr55和TNF-sr75)的变化模式没有差异。然而,在非脓毒症患者中,内毒素血症患者的TNF-sr75水平高于无内毒素血症者。而TNF-sr55未观察到这种差异,这表明两种可溶性受体的释放机制或敏感程度不同。无论疾病严重程度如何,所有三种分子(TNF-α和两种受体)的水平似乎在大致相同的时间点开始升高。TNF-α的峰值水平比两种TNF-sr的峰值水平更早达到(2 - 4小时),而两种TNF-sr的峰值水平在4 - 8小时达到。TNF-α的相对升高幅度大于可溶性受体,这种差异在脓毒症更严重的患者中更为明显。TNF-α峰值与TNF-sr峰值之间的关系呈非线性,并且在TNF-α水平较高时,每种TNF-sr的浓度似乎趋于平稳。这表明有限储备的耗尽或释放速率的饱和。综上所述,这些结果表明脓毒症的发生是因为与TNF-α相比,TNF-sr的分泌延迟且不足。